Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients
- 1 February 2006
- journal article
- research article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 29 (1) , 92-98
- https://doi.org/10.1007/s10545-006-0121-6
Abstract
Background. In Gaucher disease, the infiltration of the bone marrow by glucocerebroside-laden macrophages (Gaucher cells) triggers a diverse pattern of skeletal disease that results in crippling complications. Reliable ascertainment of the severity and pattern of skeletal disease is essential to determine disease status and the response to enzyme replacement therapy (ERT). Although there is ample documentation of reversal of haematological and visceral disease by ERT, there is a paucity of data on skeletal response to ERT in children. Aim. To delineate the pattern of bone disease in children with Gaucher disease in Egypt and to evaluate its response to ERT. Method. Twenty-two children with Gaucher disease were treated with ERT. Phenotyping by clinical, laboratory and radiological criteria was performed at baseline and following 11.2 ± 4 months of ERT. Genotyping for glucocerebrosidase (GBA) mutations was performed by gene sequencing, and genotype–phenotype correlations were performed. Results. Two-thirds of the patients were from consanguineous pedigrees and 14/22 patients were homozygous or compound heterozygous for L444P and D409H mutations. Bone involvement was detected by plain radiology in 11 children (50%) and in 16 (73%) by magnetic resonance imaging (MRI). There was no correlation of severity of bone involvement and GBA genotype. ERT ameliorated bone disease: 10 of the 11 children with abnormal radiographic findings at baseline showed improvement in skeletal lesions; while 9/16 showed improvement of marrow disease by MRI. Radiographic sensitivity and specificity were 62% and 82% compared to MRI for detection of bone involvement in this patient population. At baseline, bone pain was present in 5 patients and ERT resulted in complete symptomatic remission in all of them. ERT was associated with significant improvement in growth parameters and amelioration of haematological and visceral involvement. Conclusion. Symptomatic and radiological skeletal disease is common in children with Gaucher disease in Egypt. MRI is the most accurate technique for detecting early skeletal involvement. There was no correlation between severity of skeletal involvement and GBA genotype. ERT was effective in ameliorating radiological manifestations of skeletal disease and achieving complete remission of bone pain.Keywords
This publication has 22 references indexed in Scilit:
- IntroductionSeminars in Hematology, 2004
- Therapeutic goals in the treatment of Gaucher diseaseSeminars in Hematology, 2004
- Gaucher disease: complexity in a “simple” disorderMolecular Genetics and Metabolism, 2004
- Bone complications in children with Gaucher diseaseThe British Journal of Radiology, 2002
- Response of Gaucher bone disease to enzyme replacement therapyThe British Journal of Radiology, 2002
- Imaging and quantifying skeletal involvement in Gaucher diseaseThe British Journal of Radiology, 2002
- Skeletal aspects of Gaucher disease: a reviewThe British Journal of Radiology, 2002
- Chitotriosidase as a marker of macrophage stimulationBulletin of Experimental Biology and Medicine, 2000
- Effect of Low-dose Enzyme Replacement Therapy on Bones in Gaucher Disease Patients with Severe Skeletal InvolvementBlood Cells, Molecules, and Diseases, 1996
- Synthetic substrate ß‐glucosidase activity in leukocytes: A reproducible method for the identification of patients and carriers of Gaucher's diseaseClinical Genetics, 1978